Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Peloid (therapeutic mud) treatment for temporomandibular joint (TMJ) dysfunction

Official title: The Effect of Peloid Therapy on Pain and Functional Outcomes in Patients With Temporomandibular Joint Dysfunction

Run by Uşak University · NCT07576582 · Data updated 2026-11-12

This study will try applying peloid (therapeutic mud) to the jaw and chewing muscles for two weeks to see if it reduces pain and improves jaw function in adults with temporomandibular joint dysfunction.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorUşak University
Academic / other
Locations1 site (Uşak, Merkez)
StatusRecruiting
StartedApril 1, 2026
Main results expectedJanuary 1, 2027
Study endsFebruary 1, 2027
Registry record updatedJuly 2, 2026
Trial IDNCT07576582 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with a DC/TMD diagnosis, TMJ-related pain for at least four weeks, baseline pain ≥3/10, and ability to attend daily treatments and provide informed consent are ideal candidates.

Probably not a fit

Patients with prior TMJ surgery, active infection or acute inflammation, systemic inflammatory rheumatic disease, pregnancy, open wounds or dermatitis at the application site, or recent injection/regular physical therapy for TMJ are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-group interventional study delivering local peloid therapy to the temporomandibular joint region and masticatory muscles for 20 minutes per session, five days per week over two weeks. Adults meeting DC/TMD criteria with at least four weeks of TMJ-related pain and baseline pain ≥3/10 will be enrolled, and those with prior TMJ surgery, active infection, systemic inflammatory disease, pregnancy, or skin conditions preventing application are excluded. Outcomes measured at baseline and at end of treatment include Jaw Functional Limitation Scale-8, visual analog scale for pain, Fonseca index, maximum mouth opening, and secondary otalgia assessment. The protocol aims to provide standardized, short-course local thermotherapy data where prospective evidence for peloid use in TMJ dysfunction is limited.

Why it matters

Potential benefit: If effective, this could offer a noninvasive, low-cost option to reduce TMJ pain, improve jaw function, and potentially relieve referred ear pain.

How similar studies have gone: Small trials and balneotherapy reports suggest mud/peloid treatments can help musculoskeletal pain, but prospective data specific to temporomandibular joint dysfunction are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Diagnosis of temporomandibular joint dysfunction based on DC/TMD criteria
* Presence of TMJ-related pain for at least 4 weeks
* Baseline pain intensity ≥3 on a 0-10 visual analog scale
* Ability to provide written informed consent

Exclusion Criteria:

* History of temporomandibular joint trauma, tumor, active infection, or acute inflammation
* Previous temporomandibular joint surgery
* Presence of systemic inflammatory rheumatologic disease
* Pregnancy
* Open wound, active dermatitis, or skin condition preventing peloid application at the treatment site
* Injection therapy (e.g., botulinum toxin) or regular physical therapy for TMJ within the past 3 months
* Any clinical or behavioral condition that may interfere with study compliance

Where it's running

  • Uşak University Faculty of Medicine
    Uşak, Merkez, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.